期刊文献+

草酸铂联合亚叶酸钙、氟尿嘧啶治疗晚期大肠癌28例临床观察

下载PDF
导出
摘要 28例大肠癌患者联合应用草酸铂(L-OHP)130mg/m^2静滴2h(第1天),亚叶酸钙(CF)200mg静滴2h[在氟尿嘧啶(5-Fu)之前用,第1~5天],5-FU400mg/m^2。静滴6~8h(第1~5天)治疗,21d为一周期。至少完成3个周期后评价近期疗效。结果CR1例,PR9例,SD12例,PD6例,总有效率35.7%。主要不良反应为周围神经毒性,恶心呕吐,骨髓抑制,多为Ⅰ~Ⅱ度,不良反应较轻,停药后均可恢复。认为L—OHP联合CF、5-Fu治疗晚期大肠癌,近期疗效较好,不良反应低,患者可耐受。
机构地区 章丘市人民医院
出处 《山东医药》 CAS 北大核心 2007年第36期85-86,共2页 Shandong Medical Journal
  • 相关文献

参考文献2

二级参考文献8

  • 1Sun Y ,Guan ZZ,Jin ML,et al. A multi-center randomized phaseⅡ trial if Oxaliplatin alone and in combination in patients with advanced colorectal cancer in China [J].Proc Asco, 1999,18 (5):2559.
  • 2Paulo Hoff.Treatment of advanced colorectal with Xeloda and 5-Fu/Lv [J]. Ann Onclolgy ,2000,11 (supple 4):6.
  • 3Bernd Brockman. Treatment of metastatic colorectal with Xeloda [J]. Ann Oncology ,2000, 11 (suppl 4): 55.
  • 4Hoff PM. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase Ⅲ study [J].Clin Onclo, 2001,19(8):2282.
  • 5Borner MM. Phase Ⅱ study of capecitabine and oxaliplatin in first-and second-line treatment of advanced or metastatic colorectal cancer [J].Clin Oncol ,2002,20(7):1759.
  • 6Zeuli M.Phase Ⅱ study of capecitabine and oxaliplatin as first-line treatment in advanced colorectal cancer [J].Ann Oncol, 2003,14(9):1378.
  • 7Sumpter K.Oxaliplatin and capecitabine chemotherapy for advanced colorectal cancer:a single institution's experience[J]. Clin Oncol (R Coll Radiol ), 2003, 15(5):221.
  • 8孙燕,管忠震,金懋林,李维廉,李丽庆,石廷章,周立中,隋广杰,许立功,宋恕平,许德凤,李容,李扬,黄富麟,张嘉庆,张和平,鞠利雅.奥沙利铂单药或与氟尿嘧啶-甲酰四氢叶酸联合应用治疗晚期大肠癌Ⅱ期临床试用报告[J].癌症,1999,18(3):237-240. 被引量:344

共引文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部